ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc.

April 27, 2009 17:00 ET

ProMetic Provides Information for its Annual and Special Meeting of Shareholders

MONTREAL, QUEBEC--(Marketwire - April 27, 2009) - ProMetic Life Sciences Inc. ("ProMetic") (TSX:PLI) will host its Annual and Special Meeting of Shareholders ("Meeting") on Wednesday, May 6, 2009 at 10:30 a.m. (EDT) in the auditorium located on the fourth floor of the Montreal Stock Exchange Tower, 800 Victoria Square in Montreal. Points to be covered are:

- Items on the Meeting's agenda as per the Management Information Circular

- Corporate Presentation

For those who are unable to attend in person, the Company will offer a live audio web cast through ProMetic's website on the Events page - and in the Highlights section of the Home page - A replay of the web cast will be available following the meeting on ProMetic's website.

About ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. ("ProMetic") ( is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand™ technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montreal (Canada), ProMetic has R&D facilities in the U.K., the U.S. and Canada, manufacturing facilities in the U.K. and business development activities in the U.S., Europe, Asia and in the Middle-East.

Contact Information